✷ Report Code: A03632 | Aug 2023 | Pages: 212 | ||
Tables: 124 | Charts: 29 |
|
The global contrast injector systems market was valued at $755.57 million in 2020, and is projected to reach $1.5 billion by 2030, growing at a CAGR of 7.3% from 2021 to 2030. A contrast injector system is a medical diagnostic device that makes use of a contrast media to create visual representations of the interior of the human body to diagnose, monitor, or treat clinical disorders. The key imaging process includes, computed tomography, magnetic resonance imaging, and angiography. The contrast media enhances the contrast structures or visibility of fluids within the body as compared to traditional image processing. For instance, it is used to improve the visibility of blood vessels and gastrointestinal tract. These systems include various components, such as injector systems, consumables, and accessories. Consumables consist of injector head, syringes, tubing, and other consumables, whereas, accessories consist of hand switch, extension cable, face plate assembly, pressure jacket, syringe assembly, heater blanket assembly, coiled hand switch, and remote hand switch bracket.
The overall impact of COVID-19 remains negative on the contrast injector system market, owing to decline in number of geriatric patient visits in hospitals & clinics for various chronic diseases, such as cancer, heart diseases, Alzheimer’s, and dementia. In addition, number of patients coming for CT and MRI also declined, as these patients are more vulnerable to the COVID-19 infection, which led to decline in demand for contrast injector system products.
Contrast injector system is expected to exhibit significant market growth during the forecast period, owing to increase in imaging procedures and rapid incidence of various chronic diseases, such as cancer, heart diseases, Alzheimer’s, and dementia. The key factors that drive the growth of market increase in geriatric population coupled with high prevalence of chronic diseases globally. However, high cost of contrast injectors systems and high risk associated with contrast injector system are expected to restrict the market growth. Moreover, surge in healthcare expenditure and emergence of complex diseases in developing countries are expected to create lucrative opportunities for key market players.
The contrast injector system market is segmented on the basis of product type, application, end user, and region. According to product type, the market is divided into injector systems, consumables, and accessories. On the basis of application, the market is divided into interventional radiology, interventional cardiology, and radiology. On the basis of end user, the market is divided into diagnostic centers, clinics, hospitals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
Product Type Segment Review
By type, the contrast injector system market is divided into injector systems, consumables, and accessories. The consumables segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, owing to the growth in number of imaging procedures, such as CT, MRI, and angiography. On the other side, the demand for injector system is projected to exhibit the fastest market growth during the forecast period, owing to rise in incidence of chronic ailments such as various types of cancer, Alzheimer’s, and dementia, and other diseases, which is expected to create a demand for diagnostic procedures for precise treatment.
Application Segment Review
By application, the contrast injector systems market size classified as interventional radiology, interventional cardiology, and radiology. The interventional radiology segment presently dominates the contrast injector systems market size, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth of contrast injector systems market share, owing to reduced risks, lower cost, and higher level of comfort, shorter hospital stays, and quicker recover. In addition, different diagnostic procedures that can be performed using interventional radiology include, angiography, cholangiography, and biopsy.
End User Segment Review
By end user, the contrast injector systems industry is classified as diagnostic centers, clinics, hospitals, and others. The hospitals segment presently dominates the contrast injector systems market forecast, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate of contrast injector systems market opportunity owing to adoption of latest imaging technologies at the earliest to offer effective examination of functional areas, which were not visible by older or conventional technologies. These factors are driving the contrast injector systems market growth.
Region Segment Review
By region, the contrast injector system market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the contrast injector systems industry in 2020, accounting for the highest contrast injector systems market share, and is anticipated to maintain this trend during the forecast period. The research activities for contrast injector system are soaring in North America, owing to the well-established healthcare facilities, recent technological advancements, and rise in demand for early diagnosis of chronic diseases due to increase in awareness regarding contrast injectors.
This report provides comprehensive competitive analysis and profiles of prominent market players, such as key players operating in Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd., Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
Key Benefits For Stakeholders
Contrast Injector Systems Market Report Highlights
Aspects | Details |
---|---|
Market Size By 2030 | USD 1.5 billion |
Growth Rate | CAGR of 7.3% |
Forecast period | 2020 - 2030 |
Report Pages | 212 |
By Product Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Vivid Imaging, Medtron AG, Bayer Healthcare LLC, Ulrich GmbH & Co. KG, Shenzhen Seacrown Electromechanical Co., Ltd., Guerbet Group, Sino Medical- Device Technology Co., Ltd., Bracco Imaging S.p.A, Nemoto Kyorindo Co. Ltd., GE Healthcare |
Analyst Review
Utilization of contrast injector system is expected to witness significant growth in the near future, owing to increase in diagnosis of chronic diseases. Contrast injector systems are gaining traction among healthcare providers, as they offer benefits for the diagnosis and treatment of clinical disorders coupled with evolving indications of these systems.
Significant technological advancements in contrast injector systems lead to the provision of advanced treatment options for the management of chronic disease patients. The demand for contrast injector systems is on a continuous rise, due to surge in geriatric population prone to chronic diseases and increase in number of diagnostic procedures globally. As the market is saturated and growing at a steady rate in developed nations, the Asia-Pacific and LAMEA regions are expected to offer ample growth opportunities to key players in the market.
Escalation in incidence of chronic diseases, such as cancer and various heart ailments and increased emphasis on early prevention are some of the major factors that drive the market growth. However, high cost of the injector systems and certain side effects of the contrast media hamper the contrast injector systems market growth to some extent.
Currently, by product type, consumables is the largest segment in terms of revenue for contrast injector systems market, attributed to increase in occurrence of chronic diseases patients as the mean age of the global population shifts toward older age groups and hectic lifestyle leading to stress in daily life, which increases with the number of procedures conducted. In addition, CT injector system accounted for the highest share in 2016, owing to rapid CT scanner installations and increase in number of diagnostic imaging processes.
This is specifically due to the high demand for CT scans for neuroimaging with contrast injectors, as these are best suited for neurological investigations, such as intracranial hemorrhage, brain injuries, tumor, and acute neurological changes.
Moreover, emerging markets gain importance for majority of the contrast injector system manufacturers and distributors, as they focus towards unmet demand for diagnosing diseases in these regions. Hence, many companies have started introducing technologically advanced products to cater the needs of the rise in population, especially in developing economies. For instance, Bracco Imaging launched injector systems for personalized patient care and reduced cost savings in 2016. The novel software-enabled contrast injector systems not only track patients’ current health status, but also alert the physician for any adverse reactions. Rapid growth was observed in the shipments of these devices to provide improved healthcare services in emerging nations, and this is expected to offset the challenging conditions in mature markets, such as North America and Europe. North America is expected to dominate the global contrast injector system market during the forecast period, followed by Europe.
Contrast injector systems are medical devices used to enhance the visibility of body structures, such as tissues, body fluids, arteries, and others. Contrast injector systems utilize contrast media, which aids in enhancing the visibility of blood vessels and gastrointestinal tract. Contrast injector systems are used to diagnose various types of diseases such as cancer, dementia, Alzheimer’s, respiratory diseases, and lung diseases.
Advanced healthcare settings are rapidly adopting contrast injector systems as these injector systems offer detailed images through computed tomography (CT), magnetic resonance imaging (MRI), angiography, and others. Technological advancements aid in the development of cost efficient and fully automated contrast injector systems. These automated contrast injectors support radiologist or other healthcare professionals by reducing the odds of human error and enabling personalized patient care. However, the high cost of contrast injector systems coupled with the risks involved with contrast media impede the market growth.
There have been significant technological advancements in contrast injector systems, which have led to provision of advanced treatment options for the management of chronic disease patients. The demand for contrast injector systems is on a continuous rise due to surge in geriatric population prone to chronic diseases and increase in number of diagnostic procedures globally. As the market is saturated and growing at a steady rate in the developed nations, Asia-Pacific and LAMEA are expected to offer ample growth opportunities to the key players in this market.
Currently, consumables is the largest segment in terms of revenue for contrast injector systems market, attributable to increase in occurrence of chronic diseases patients as the mean age of the global population shifts toward older age groups and hectic lifestyle leading to stress in daily life, which increases with the number of procedures conducted. In addition, CT injector system accounted for the highest share in 2016, owing to rapid CT scanner installations along with increase in number of diagnostic imaging processes.
This is specifically due to the high demand for CT scans for neuroimaging with contrast injectors, as these are best suited for neurological investigations such as intracranial hemorrhage, brain injuries, tumor, and acute neurological changes.
Moreover, emerging markets are gaining importance for majority of the contrast injector system manufacturers and distributors, as they are focusing towards unmet demand for diagnosing diseases in these regions. Hence, many companies have started introducing technologically advanced products to cater the needs of the rise in population, especially in developing economies. For instance, Bracco Imaging launched injector systems for personalized patient care and reduced cost savings. The novel software-enabled contrast injector systems not only track the patient’s current health status, but also alert the physician for any adverse reactions. A rapid growth was observed in the shipments of these devices to provide improved healthcare services in emerging nations, and this is expected to offset the challenging conditions in mature markets such as North America and Europe.
A. the trends of Contrast Injector Systems Market are rise in incidence of chronic ailments such as various types of cancer, Alzheimer’s, and dementia, and other diseases, which is expected to create a demand for diagnostic procedures for precise treatment.
A. The leading application of Contrast Injector Systems Market are interventional radiology, interventional cardiology, and radiology.
A. North America is the largest regional market for Contrast Injector Systems.
A. Contrast Injector Systems Market is projected to reach $ 1529.38 million by 2030, registering a CAGR of 7.3% from 2021 to 2030.
A. The top companies to hold the market share in Contrast Injector Systems are Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd., Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers